Fortacin™ was filed with the European Medicines Agency (EMA) in May 2012, and obtained a marketing authorization from the European Commission on 19 November 2013.
Global licensing and distribution opportunities for Fortacin™ are now available. For further information please contact:
CSO, Plethora Solutions
T: +44 20 3077 5400